- 英文名称
- (+)-Eclalbasaponin I
- 分子式
- C42H68O14
- 分子量
- 796.98
- 中文别名
- Eclalbasaponin I; Eclalbasaponin I; 1-O-[(3β,5ξ,9ξ,14ξ)-3-(D-erythro-Hexopyranosyloxy)-16-hydroxy-28-oxoolean-12-en-28-yl]-α-D-glycero-hexopyranose; [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bS)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate; ecliptasaponin C; ((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl) (4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bS)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate; (2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4aR,5R,6aS,6bR,8aR,10S,12aR,12bR,14bS)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate; 1-O-[3beta-(beta-D-Glucopyranosyloxy)-16alpha-hydroxy-28-oxoolean-12-en-28-yl]-beta-D-glucopyranose; (3β,16α)-3-(β-D-Glucopyranosyloxy)-16-hydroxyolean-12-en-28-oic acid β-D-glucopyranosyl ester; Olean-12-en-28-oic acid, 3-(β-D-glucopyranosyloxy)-16-hydroxy-, β-D-glucopyranosyl ester, (3β,16α)-
- 用途
- Eclalbasaponin I 作为中草药成分，具有抗肿瘤活性，可抑制肝癌细胞 smmc-7721 的增殖，其 IC50 值为 111.1703 μg/ml，主要应用于生命科学领域的抗肿瘤相关研究。
